Advantage Solutions and Daymon’s Private Brand Intelligence Report Reveals How Value, Wellness, and Seasonal Flavor Trends Are Reshaping Holiday Shopping Habits

ST. LOUIS, Nov. 12, 2026 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV), the leading omnichannel retail solutions agency in North America, and its private brands business, Daymon, today released the Holiday 2026 Private Brand Intelligence Report (PBIR). A top finding in the proprietary report shows that 82% of consumers plan to purchase private brands this holiday season.

“No season tells us more about what consumers value than the holidays, and Daymon’s research is what helps our brand and retail clients win,” said Dave Peacock, CEO of Advantage Solutions. “This year, consumers are balancing tighter budgets with the desire to celebrate, and they’re making deliberate choices about where to save. That’s where private brands and other high-value, high-quality products are driving purchasing decisions.”

By the Numbers: How Consumers Are Preparing for the Holidays

  • 93% of consumers are celebrating Thanksgiving; 95% are celebrating Christmas.
  • 52% of Gen Z plan to host Thanksgiving; 53% of millennials plan to host Christmas.
  • 87% of consumers say they will be spending the same or more on holiday groceries this year.
  • 71% of consumers choose to shop at certain retailers because of their private brands.
  • 77% of consumers plan to purchase products with seasonal flavors.
  • 69% of consumers try to balance healthy choices with holiday indulgences.

Going Deeper: Research-Backed Trends Shaping the Holiday Season

  • Holiday Flavors and Scents Are in Demand: Seasonal flavors and scents continue to drive holiday purchases, with interest strongest among younger generations. This section reviews the top holiday flavors of the year and how retailers are using scents and shapes to bring the season to life.
  • The Ingredients to Weather-Proof Your Limited-Time Offer Program: Seasonal limited-time offer (LTO) programs are now a fixture of retail strategy, but a selling window of a few weeks often requires a year or more of planning. This section outlines how retailers can align teams, build the right assortment, and manage operational risks to deliver a successful program.
  • Finding the Holiday Balance: Financial pressure and year-round wellness priorities are reshaping how consumers shop for the holidays. This section explores how private brands can meet evolving expectations and deliver greater overall value, helping shoppers stretch their budgets and balance health-oriented choices with seasonal indulgences.
  • A Look at Non-Foods: While food drives the majority of private brand sales, categories like pet, home, and decor are a growing force. This section examines how a clear non-foods strategy can create new opportunities for future holiday seasons.

“Consumers increasingly see private brands as a holiday staple they can trust, choosing them for quality as much as value,” said Christine Boenig, President of Daymon North America. “That trust gives retailers an opening to innovate, from seasonal flavors to new products built for every holiday occasion, and this report is designed to give them a head start on 2027. Whether retailers are refining their holiday lineup or building something new, Daymon’s product development and quality assurance expertise helps them turn these insights into private brand growth.”

Daymon has independently produced its PBIR since 2018, with current editions released twice a year to showcase summer and holiday consumer habits. The Holiday 2026 edition includes proprietary research from two national surveys of adult consumers responsible for shopping in their households. In total, the two studies received more than 2,000 responses from consumers about their purchasing behavior, perceptions around private brands, and seasonal shopping considerations.

The Holiday 2026 PBIR is part of Advantage360, the thought leadership platform of Advantage Solutions that delivers data-driven insights and research across the consumer goods and retail industries. To read the full report, download it here.

About Advantage Solutions

Advantage Solutions is the leading omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers. With its data- and technology-powered services, Advantage leverages its unparalleled insights, expertise and scale to help brands and retailers of all sizes generate demand and get products into the hands of consumers, wherever they shop. Whether it’s creating meaningful moments and experiences in-store and online, optimizing assortment and merchandising, or accelerating e-commerce and digital capabilities, Advantage is the trusted partner that keeps commerce and life moving. Advantage has offices throughout North America and strategic investments and owned operations in select international markets. For more information, please visit YourADV.com.

About Daymon

Daymon is a leading private brand agency with decades of experience partnering with global manufacturers, retailers, and brands. Through a comprehensive suite of solutions including brand strategy, analytics and insights, category management, product development, sourcing, quality assurance, and creative design, Daymon helps clients build private brand programs that deliver lasting value and earn lasting shopper loyalty. Daymon is a subsidiary of Advantage Solutions. For more information, please visit Daymon.com.

Media Contact:
Katie Russo, Advantage Solutions
press@youradv.com
501-282-5069

Advantage Solutions and Daymon’s Private Brand Intelligence Report Reveals How Value, Wellness, and Seasonal Flavor Trends Are Reshaping Holiday Shopping Habits

ST. LOUIS, Nov. 12, 2026 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV), the leading omnichannel retail solutions agency in North America, and its private brands business, Daymon, today released the Holiday 2026 Private Brand Intelligence Report (PBIR). A top finding in the proprietary report shows that 82% of consumers plan to purchase private brands this holiday season.

“No season tells us more about what consumers value than the holidays, and Daymon’s research is what helps our brand and retail clients win,” said Dave Peacock, CEO of Advantage Solutions. “This year, consumers are balancing tighter budgets with the desire to celebrate, and they’re making deliberate choices about where to save. That’s where private brands and other high-value, high-quality products are driving purchasing decisions.”

By the Numbers: How Consumers Are Preparing for the Holidays

  • 93% of consumers are celebrating Thanksgiving; 95% are celebrating Christmas.
  • 52% of Gen Z plan to host Thanksgiving; 53% of millennials plan to host Christmas.
  • 87% of consumers say they will be spending the same or more on holiday groceries this year.
  • 71% of consumers choose to shop at certain retailers because of their private brands.
  • 77% of consumers plan to purchase products with seasonal flavors.
  • 69% of consumers try to balance healthy choices with holiday indulgences.

Going Deeper: Research-Backed Trends Shaping the Holiday Season

  • Holiday Flavors and Scents Are in Demand: Seasonal flavors and scents continue to drive holiday purchases, with interest strongest among younger generations. This section reviews the top holiday flavors of the year and how retailers are using scents and shapes to bring the season to life.
  • The Ingredients to Weather-Proof Your Limited-Time Offer Program: Seasonal limited-time offer (LTO) programs are now a fixture of retail strategy, but a selling window of a few weeks often requires a year or more of planning. This section outlines how retailers can align teams, build the right assortment, and manage operational risks to deliver a successful program.
  • Finding the Holiday Balance: Financial pressure and year-round wellness priorities are reshaping how consumers shop for the holidays. This section explores how private brands can meet evolving expectations and deliver greater overall value, helping shoppers stretch their budgets and balance health-oriented choices with seasonal indulgences.
  • A Look at Non-Foods: While food drives the majority of private brand sales, categories like pet, home, and decor are a growing force. This section examines how a clear non-foods strategy can create new opportunities for future holiday seasons.

“Consumers increasingly see private brands as a holiday staple they can trust, choosing them for quality as much as value,” said Christine Boenig, President of Daymon North America. “That trust gives retailers an opening to innovate, from seasonal flavors to new products built for every holiday occasion, and this report is designed to give them a head start on 2027. Whether retailers are refining their holiday lineup or building something new, Daymon’s product development and quality assurance expertise helps them turn these insights into private brand growth.”

Daymon has independently produced its PBIR since 2018, with current editions released twice a year to showcase summer and holiday consumer habits. The Holiday 2026 edition includes proprietary research from two national surveys of adult consumers responsible for shopping in their households. In total, the two studies received more than 2,000 responses from consumers about their purchasing behavior, perceptions around private brands, and seasonal shopping considerations.

The Holiday 2026 PBIR is part of Advantage360, the thought leadership platform of Advantage Solutions that delivers data-driven insights and research across the consumer goods and retail industries. To read the full report, download it here.

About Advantage Solutions

Advantage Solutions is the leading omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers. With its data- and technology-powered services, Advantage leverages its unparalleled insights, expertise and scale to help brands and retailers of all sizes generate demand and get products into the hands of consumers, wherever they shop. Whether it’s creating meaningful moments and experiences in-store and online, optimizing assortment and merchandising, or accelerating e-commerce and digital capabilities, Advantage is the trusted partner that keeps commerce and life moving. Advantage has offices throughout North America and strategic investments and owned operations in select international markets. For more information, please visit YourADV.com.

About Daymon

Daymon is a leading private brand agency with decades of experience partnering with global manufacturers, retailers, and brands. Through a comprehensive suite of solutions including brand strategy, analytics and insights, category management, product development, sourcing, quality assurance, and creative design, Daymon helps clients build private brand programs that deliver lasting value and earn lasting shopper loyalty. Daymon is a subsidiary of Advantage Solutions. For more information, please visit Daymon.com.

Media Contact:
Katie Russo, Advantage Solutions
press@youradv.com
501-282-5069

Märt Meerits was appointed Chief Financial Officer of Arco Vara AS on 12 November 2026. The current Chief Financial Officer, Darja Boshakova, will leave the company in December 2026. Until her departure, Bolshakova will ensure a smooth handover of financial management responsibilities.

Under the leadership of Kert Keskpaik, who took office as CEO of Arco Vara AS on 8 October 2026, the company is focusing on improving capital efficiency and placing the profitability of development projects at the core of its operations.

Kert Keskpaik, CEO of Arco Vara AS, commented: “The next phase of Arco Vara’s development will focus on the profitability of development projects and the efficient use of capital, with the CFO playing a central role in achieving these objectives. Märt has extensive experience in financial management, raising capital and managing a listed company. Through his involvement in the Volta Quarter development, he has gained first-hand experience in financing the redevelopment of a former industrial site. This experience will be particularly valuable in financing the next stages of the Luther Quarter development.”

“I would like to thank Darja for her excellent cooperation. Under her leadership, financial processes have been automated and a EUR 15 million bond issue was successfully completed. I highly value her professionalism and contribution to Arco Vara’s development and wish her every success in her future endeavours,” Keskpaik added.

Märt Meerits has nearly 30 years of experience in financial management, investment and corporate leadership. Most recently, he served as Chief Financial Officer of the international corporate group Cryotech Nordic. In 2025, he held a fixed-term position as Chief Financial Officer of Endover. During this period, Endover launched the largest bond programme in its history to finance the Volta SKAI development. From 2019 to 2025, Meerits served as Chief Financial Officer of Exmet Group. From 2018 to 2019, he worked as a Project Manager at Endover, and from 2015 to 2018, he was involved in raising capital for real estate projects at Crowdestate. From 2010 to 2015, Meerits was a Member of the Management Board of AS Silvano Fashion Group, a company listed on the Nasdaq Tallinn and Warsaw stock exchanges. Previously, he served as Chief Executive Officer (CEO) and Head of Investments at Trilliance Capital AG, Head of Investment Management at LFS Asset Management, Member of the Management Board of SEB Varahaldus AS, and Head of Private Banking at SEB. Meerits graduated from Estonian Business School with a degree in International Business Administration and holds an Executive MBA from the Stockholm School of Economics in Riga.

Märt Meerits does not own any shares in Arco Vara AS.

The change of Chief Financial Officer will not result in any changes to the composition of the Management Board or Supervisory Board of Arco Vara AS. Märt Meerits will become a Member of the Management Board of all Estonian subsidiaries of Arco Vara AS.

Kert Keskpaik
CEO
Arco Vara AS
kert.keskpaik@arcovara.com  

Märt Meerits was appointed Chief Financial Officer of Arco Vara AS on 12 November 2026. The current Chief Financial Officer, Darja Boshakova, will leave the company in December 2026. Until her departure, Bolshakova will ensure a smooth handover of financial management responsibilities.

Under the leadership of Kert Keskpaik, who took office as CEO of Arco Vara AS on 8 October 2026, the company is focusing on improving capital efficiency and placing the profitability of development projects at the core of its operations.

Kert Keskpaik, CEO of Arco Vara AS, commented: “The next phase of Arco Vara’s development will focus on the profitability of development projects and the efficient use of capital, with the CFO playing a central role in achieving these objectives. Märt has extensive experience in financial management, raising capital and managing a listed company. Through his involvement in the Volta Quarter development, he has gained first-hand experience in financing the redevelopment of a former industrial site. This experience will be particularly valuable in financing the next stages of the Luther Quarter development.”

“I would like to thank Darja for her excellent cooperation. Under her leadership, financial processes have been automated and a EUR 15 million bond issue was successfully completed. I highly value her professionalism and contribution to Arco Vara’s development and wish her every success in her future endeavours,” Keskpaik added.

Märt Meerits has nearly 30 years of experience in financial management, investment and corporate leadership. Most recently, he served as Chief Financial Officer of the international corporate group Cryotech Nordic. In 2025, he held a fixed-term position as Chief Financial Officer of Endover. During this period, Endover launched the largest bond programme in its history to finance the Volta SKAI development. From 2019 to 2025, Meerits served as Chief Financial Officer of Exmet Group. From 2018 to 2019, he worked as a Project Manager at Endover, and from 2015 to 2018, he was involved in raising capital for real estate projects at Crowdestate. From 2010 to 2015, Meerits was a Member of the Management Board of AS Silvano Fashion Group, a company listed on the Nasdaq Tallinn and Warsaw stock exchanges. Previously, he served as Chief Executive Officer (CEO) and Head of Investments at Trilliance Capital AG, Head of Investment Management at LFS Asset Management, Member of the Management Board of SEB Varahaldus AS, and Head of Private Banking at SEB. Meerits graduated from Estonian Business School with a degree in International Business Administration and holds an Executive MBA from the Stockholm School of Economics in Riga.

Märt Meerits does not own any shares in Arco Vara AS.

The change of Chief Financial Officer will not result in any changes to the composition of the Management Board or Supervisory Board of Arco Vara AS. Märt Meerits will become a Member of the Management Board of all Estonian subsidiaries of Arco Vara AS.

Kert Keskpaik
CEO
Arco Vara AS
kert.keskpaik@arcovara.com  

Märt Meerits was appointed Chief Financial Officer of Arco Vara AS on 12 November 2026. The current Chief Financial Officer, Darja Boshakova, will leave the company in December 2026. Until her departure, Bolshakova will ensure a smooth handover of financial management responsibilities.

Under the leadership of Kert Keskpaik, who took office as CEO of Arco Vara AS on 8 October 2026, the company is focusing on improving capital efficiency and placing the profitability of development projects at the core of its operations.

Kert Keskpaik, CEO of Arco Vara AS, commented: “The next phase of Arco Vara’s development will focus on the profitability of development projects and the efficient use of capital, with the CFO playing a central role in achieving these objectives. Märt has extensive experience in financial management, raising capital and managing a listed company. Through his involvement in the Volta Quarter development, he has gained first-hand experience in financing the redevelopment of a former industrial site. This experience will be particularly valuable in financing the next stages of the Luther Quarter development.”

“I would like to thank Darja for her excellent cooperation. Under her leadership, financial processes have been automated and a EUR 15 million bond issue was successfully completed. I highly value her professionalism and contribution to Arco Vara’s development and wish her every success in her future endeavours,” Keskpaik added.

Märt Meerits has nearly 30 years of experience in financial management, investment and corporate leadership. Most recently, he served as Chief Financial Officer of the international corporate group Cryotech Nordic. In 2025, he held a fixed-term position as Chief Financial Officer of Endover. During this period, Endover launched the largest bond programme in its history to finance the Volta SKAI development. From 2019 to 2025, Meerits served as Chief Financial Officer of Exmet Group. From 2018 to 2019, he worked as a Project Manager at Endover, and from 2015 to 2018, he was involved in raising capital for real estate projects at Crowdestate. From 2010 to 2015, Meerits was a Member of the Management Board of AS Silvano Fashion Group, a company listed on the Nasdaq Tallinn and Warsaw stock exchanges. Previously, he served as Chief Executive Officer (CEO) and Head of Investments at Trilliance Capital AG, Head of Investment Management at LFS Asset Management, Member of the Management Board of SEB Varahaldus AS, and Head of Private Banking at SEB. Meerits graduated from Estonian Business School with a degree in International Business Administration and holds an Executive MBA from the Stockholm School of Economics in Riga.

Märt Meerits does not own any shares in Arco Vara AS.

The change of Chief Financial Officer will not result in any changes to the composition of the Management Board or Supervisory Board of Arco Vara AS. Märt Meerits will become a Member of the Management Board of all Estonian subsidiaries of Arco Vara AS.

Kert Keskpaik
CEO
Arco Vara AS
kert.keskpaik@arcovara.com  

MONTREAL, Nov. 12, 2026 (GLOBE NEWSWIRE) — Tracy Robinson, President and Chief Executive Officer of CN (TSX: CNR) (NYSE: CNI), will address the 26th Annual Scotiabank Transportation and Industrials Conference on November 18, 2026, at 8:00 a.m. Eastern Time (ET).

CN will provide a live webcast via the Investors section of its website at www.cn.ca/investors. A replay of the webcast will be available following the event.

About CN
CN powers the economy by safely transporting more than 300 million tons of natural resources, manufactured products, and finished goods throughout North America every year for its customers. With its nearly 20,000-mile rail network and related transportation services, CN connects Canada’s Eastern and Western coasts with the U.S. Midwest and the U.S. Gulf Coast, contributing to sustainable trade and the prosperity of the communities in which it operates since 1919.

Contacts:
 
   
Media Investment Community
Ashley Michnowski Jamie Lockwood
Senior Manager Vice-President
Media Relations Investor Relations & Special Projects
(438) 596-4329 (514) 399-0052
media@cn.ca investor.relations@cn.ca

MONTREAL, Nov. 12, 2026 (GLOBE NEWSWIRE) — Tracy Robinson, President and Chief Executive Officer of CN (TSX: CNR) (NYSE: CNI), will address the 26th Annual Scotiabank Transportation and Industrials Conference on November 18, 2026, at 8:00 a.m. Eastern Time (ET).

CN will provide a live webcast via the Investors section of its website at www.cn.ca/investors. A replay of the webcast will be available following the event.

About CN
CN powers the economy by safely transporting more than 300 million tons of natural resources, manufactured products, and finished goods throughout North America every year for its customers. With its nearly 20,000-mile rail network and related transportation services, CN connects Canada’s Eastern and Western coasts with the U.S. Midwest and the U.S. Gulf Coast, contributing to sustainable trade and the prosperity of the communities in which it operates since 1919.

Contacts:
 
   
Media Investment Community
Ashley Michnowski Jamie Lockwood
Senior Manager Vice-President
Media Relations Investor Relations & Special Projects
(438) 596-4329 (514) 399-0052
media@cn.ca investor.relations@cn.ca

MONTREAL, Nov. 12, 2026 (GLOBE NEWSWIRE) — Tracy Robinson, President and Chief Executive Officer of CN (TSX: CNR) (NYSE: CNI), will address the 26th Annual Scotiabank Transportation and Industrials Conference on November 18, 2026, at 8:00 a.m. Eastern Time (ET).

CN will provide a live webcast via the Investors section of its website at www.cn.ca/investors. A replay of the webcast will be available following the event.

About CN
CN powers the economy by safely transporting more than 300 million tons of natural resources, manufactured products, and finished goods throughout North America every year for its customers. With its nearly 20,000-mile rail network and related transportation services, CN connects Canada’s Eastern and Western coasts with the U.S. Midwest and the U.S. Gulf Coast, contributing to sustainable trade and the prosperity of the communities in which it operates since 1919.

Contacts:
 
   
Media Investment Community
Ashley Michnowski Jamie Lockwood
Senior Manager Vice-President
Media Relations Investor Relations & Special Projects
(438) 596-4329 (514) 399-0052
media@cn.ca investor.relations@cn.ca

SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) — Olema Oncology, Inc. (formerly Olema Pharmaceuticals, Inc.) (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, announced that, effective today, it has changed its corporate name from “Olema Pharmaceuticals, Inc.” to “Olema Oncology, Inc.” pursuant to the Company’s Eighth Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware.

The Company’s common stock will continue to be listed and trade on the Nasdaq Global Select Market under the ticker symbol “OLMA.” Pursuant to Delaware law, no action was required by stockholders of the Company to effect the name change. Stock certificates reflecting the prior corporate name will continue to be valid.

About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor antagonist (CERAN) and a selective estrogen receptor degrader (SERD), currently in two Phase 3 clinical trials. In addition, Olema is developing OP-3136, a potent lysine acetyltransferase 6 (KAT6) inhibitor, now in a Phase 1 clinical study. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit www.olema.com.

Media and Investor Relations Contact
Courtney O’Konek
Vice President, Corporate Communications
Olema Oncology
media@olema.com

SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) — Olema Oncology, Inc. (formerly Olema Pharmaceuticals, Inc.) (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, announced that, effective today, it has changed its corporate name from “Olema Pharmaceuticals, Inc.” to “Olema Oncology, Inc.” pursuant to the Company’s Eighth Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware.

The Company’s common stock will continue to be listed and trade on the Nasdaq Global Select Market under the ticker symbol “OLMA.” Pursuant to Delaware law, no action was required by stockholders of the Company to effect the name change. Stock certificates reflecting the prior corporate name will continue to be valid.

About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor antagonist (CERAN) and a selective estrogen receptor degrader (SERD), currently in two Phase 3 clinical trials. In addition, Olema is developing OP-3136, a potent lysine acetyltransferase 6 (KAT6) inhibitor, now in a Phase 1 clinical study. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit www.olema.com.

Media and Investor Relations Contact
Courtney O’Konek
Vice President, Corporate Communications
Olema Oncology
media@olema.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.